Real-world effectiveness and safety of tofacitinib and abatacept in patients with rheumatoid arthritis.
Wataru HiroseMasayoshi HarigaiKoichi AmanoToshihiko HidakaKenji ItohKazutoshi AokiMasahiro NakashimaHayato NagasawaYukiko KomanoToshihiro NankiPublished in: Rheumatology advances in practice (2022)
The present results suggest that TOF is more effective with regard to remission at week 52 based on treatment responses in SE-negative RA patients.
Keyphrases